1. Scrip

OPPI Head On Sustaining Supplies In India During The Pandemic

 
• By Anju Ghangurde

OPPI director general and ex-MSD India chief outlines how pharma in India is ensuring medicines reach patients amid COVID-19, working closely with various stakeholders. De-risking the supply chain and up-skilling sales forces in view of widespread digital engagement are among the key issues firms are addressing.

India
Pharma In India Working With Stakeholders To Maintain Supplies • Source: Shutterstock

Industry veteran K G Ananthakrishnan took charge earlier this year as director general of the Organization of Pharmaceutical Producers of India (OPPI), which represents foreign drug firms in the country, amid disruption across pharma’s operations as a result of the raging coronavirus pandemic. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia